MSD, a unit of Merck Ltd is planning to set up a lab for developing vaccines in joint venture with Wellcome Trust Hilleman Laboratories (the Hilleman Labs - a London based research charity) in India. It will come up at Delhi Jamia Millia Islamia University campus and will entail an investment of USD 150 million. MSD has already developed a vaccine for rotavirus which has 90% efficiency against severe gastroenteritis. The lab will focus on vaccines for disease prevalent in tropical countries
|11,950 ₹||4950 ₹||4950 ₹||4950 ₹||3950 ₹|
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony